Trial
NCT03768310
CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Baylor College of Medicine
Collaborators
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy, Baylor College of Medicine
Condition
Non-hodgkin Lymphoma
Intervention
CD19.CAR-multiVST for Group A
Why stopped
We decided to move on to another product and as a result will not be moving forward with this study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-21